ConductScience.org, home

Trial · NCT03877562

The Effect of CORT118335 on Olanzapine-Induced Weight Gain

NCT03877562, Phase 1, Completed, Corcept Therapeutics

3 sourcestrials-2026-11-12-0.5.0

Download JSON
Cite this record

ConductScience Library. The Effect of CORT118335 on Olanzapine-Induced Weight Gain. Trials, record NCT03877562. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03877562

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
The Effect of CORT118335 on Olanzapine-Induced Weight Gain
NCT number
NCT03877562
Status
Completed
Phases
Phase 1
Enrollment
96 participants, actual
Lead sponsor
Corcept Therapeutics
Conditions
Antipsychotic-induced Weight Gain
Interventions
Olanzapine, CORT118335, Placebo
First posted
2019-03-15
Last updated
2020-04-28
Other registries' IDs
eudract:2019-000633-39

Source ClinicalTrials.gov

Registered outcomes12

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryMean Change from Baseline in Body WeightPre-dose on Day 1 (Baseline) and Day 15
SecondaryPercentage of Participants with One or More Adverse EventsUp to Day 28
SecondaryPercentage of Participants with One or More Serious Adverse EventsUp to Day 28
SecondaryPercentage of Participants Discontinued from the Study due to an Adverse EventUp to Day 28
SecondaryMean Change from Baseline in GlucosePre-dose on Day 1 (Baseline), pre-dose on Days 8, 15, and 28
SecondaryMean Change from Baseline in InsulinPre-dose on Day 1 (Baseline), pre-dose on Days 8, 15, and 28
SecondaryMean Change from Baseline in Homeostatic Model Assessment of Insulin Resistance (HOMA-IR)Pre-dose on Day 1 (Baseline), pre-dose on Days 8, 15, and 28
SecondaryMean Change from Baseline in TriglyceridesPre-dose on Day 1 (Baseline), pre-dose on Days 8, 15, and 28
SecondaryMean Change from Baseline in Waist-to-Hip RatioPre-dose on Day 1 (Baseline), Days 8, 15, and 28
SecondaryPlasma Pharmacokinetics (PK) of CORT118335: Time from Dosing at which Maximum Concentration is Apparent (tmax)Pre-dose and at pre-specified time points up to 24 hours after dosing on Day 7

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03877562

GET https://conductscience.org/api/trials/v1/NCT03877562/registered